Name: ArriVent BioPharma, Inc. (AVBP) Balance Sheet
Creator: FinSpry

ArriVent BioPharma Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for ArriVent BioPharma, Inc. (AVBP) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Current Assets
Cash and Cash Equivalents	74.29	150.39	163.37	37.28
Short-Term Investments	144.57	0.00	0.00	0.00
Cash & Short-Term Investments	218.86	150.39	163.37	37.28
Accounts Receivable	0.50	0.76	0.50	0.25
Inventory	0.00	0.00	0.00	0.00
Other Current Assets	7.62	0.37	0.33	5.42
Total Current Assets	226.98	159.97	182.62	42.95
Non-Current Assets
Property, Plant & Equipment (Net)	0.15	0.29	0.14	0.00
Long-Term Investments	47.68	0.00	0.00	0.00
Other Non-Current Assets	0.13	0.11	0.07	0.09
Total Non-Current Assets	47.96	3.13	0.21	0.09
Total Assets	274.94	163.10	182.83	43.04
Current Liabilities
Accounts Payable	3.78	4.53	3.09	0.29
Short-Term Debt	0.32	0.00	0.00	0.00
Accrued Liabilities	9.17	6.95	5.14	0.61
Other Current Liabilities	13.17	0.00	0.00	0.00
Total Current Liabilities	17.27	11.62	8.36	1.82
Non-Current Liabilities
Long-Term Debt	0.01	0.18	0.01	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	0.01	304.67	259.58	0.00
Total Liabilities	17.29	11.80	8.37	1.82
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00
Retained Earnings	-238.33	-157.85	-88.51	-51.61
Accumulated Other Comprehensive Income	-0.21	0.00	0.00	0.00
Additional Paid-in Capital	496.20	4.65	3.40	2.96
Shares Outstanding	33.71	31.96	31.96	31.96
Total Stockholders' Equity	257.65	151.30	174.46	41.22
Total Liabilities & Equity	274.94	163.10	182.83	43.04